% | $
Quotes you view appear here for quick access.

Ampio Pharmaceuticals, Inc. Message Board

  • racavalli racavalli May 23, 2013 10:34 AM Flag

    Regeneron shareholders are buying AMPE

    Regeneron shareholders are buying AMPE as a hedge. Read yesterdays article in Seeking Alpha titled, "Regeneron Shareholders Watching Optina Trial Closely".

    SortNewest  |  Oldest  |  Most Replied Expand all replies
    • Do your DD. Calculate Eyleas worth and how much REGN is priced at right now. It would appear overpriced. Thats because many have not factored in what is coming. REGN727 is going to blow the market away. Then there is the Asthma drug and more to come. They have a very nice pipeline. In addition, pharma stocks are priced on potential.

      The writer was only trying to make big shareholders of REGN aware of AMPIO stock and get people to pay attention here. This is 2013. After results , if they are as positive as he wishes, how long do you think it'll take to reach the market and in what capacity. Are you aware of the blast off REGN used to advertise and sell Eylea. REGN management is something to behold. If you are going to Pump at least garnish it appropriately so as not to insult other peoples intelligence.

0.754-0.062(-7.62%)Sep 27 4:02 PMEDT